Patents Examined by Nathan R Price
  • Patent number: 11458293
    Abstract: A self-flushing connector includes a housing having a cavity, a first inlet port, a second inlet port, and an outlet port. A collapsible valve is disposed within the cavity. A first flow path extends from the first inlet port to the outlet port. The first inlet port and the second inlet port are fluidly connected through a gap defined between the body of the collapsible valve and an inner wall of the housing defining the cavity. A second flow path extends from the second inlet port to the first flow path. When the collapsible valve is in a closed state, the collapsible valve fluidly disconnects the second flow path from the first flow path while allowing fluid to flow through the first flow path. When the collapsible valve is in an open state, the second flow path is fluidly connected to the first flow path.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: October 4, 2022
    Assignee: CAREFUSION 303, INC.
    Inventors: Raymond P. Feith, Jake Randolph Smith
  • Patent number: 11457968
    Abstract: Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to methods including selectively neuromodulating afferent or efferent renal nerves. One or more measurable physiological parameters corresponding to systemic sympathetic overactivity or hyperactivity in the patient can thereby be reduced. Selectively neuromodulating afferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a renal pelvis. This can include, for example, neuromodulating via fluid within the renal pelvis. Selectively neuromodulating efferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a portion of a renal artery or a renal branch artery proximate a renal parenchyma. This can include, for example, neuromodulating via a therapeutic element within the portion of the renal artery or the renal branch artery.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: October 4, 2022
    Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
    Inventors: Stefan Tunev, Julie Trudel
  • Patent number: 11458257
    Abstract: An injection device having a delivery element with an inner thread may be driven by rotation and includes a cylindrical outer wall region, which is substantially smooth. Such features provide a delivery element configured such that it is less intimidating to patients than known threaded rods, and may facilitate easy cleaning. The delivery element may be non-rotatably guided and axially spring-loaded, and may be inserted axially into the housing when the reservoir is replaced. The driving thread element for the delivery element may be mounted in the vicinity of the distal end of the housing.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: October 4, 2022
    Assignee: Ypsomed AG
    Inventors: Philippe Kohlbrenner, Peter Stettler, Patrick Hostettler, Juergen Wittmann, Martin Wittwer
  • Patent number: 11452858
    Abstract: The anti-back-flow devices and methods prevent fluid from leaking proximally from a catheter, but allow ready access to the catheter using any male luer device. The devices include proximal surfaces that urge open a valve in response to force from a male luer tip. The valves are associated a female luer hub and adapted to function with standard and typical non-standard male luer fittings.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: September 27, 2022
    Assignee: I-V Access Technology, Inc.
    Inventors: Stephen R. Keyser, Jessie Delgado, Theodore J. Mosler
  • Patent number: 11452846
    Abstract: Some embodiments of a medical device anchor system includes an anchor sleeve and a catheter (or other medical instrument) to advance though a working channel of the anchor sleeve. The anchor sleeve may have a subcutaneous cuff device arranged along an outer surface. In such circumstances, the embedded cuff device can inhibit the migration of infection from outside the skin and into the blood stream.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: September 27, 2022
    Assignee: INTERRAD Medical, Inc.
    Inventor: Michael S. Rosenberg
  • Patent number: 11452856
    Abstract: A medical device including a connector portion having a distal end and a proximal end, and a screw groove configured for fluid communication between the connector portion and another medical device. The screw groove has a first side wall provided close to the distal end and a second side wall provided close to the proximal end. The first side wall has a stop portion whose lead angle has been reduced or eliminated.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: September 27, 2022
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventor: Toshihiko Kakinoki
  • Patent number: 11452843
    Abstract: An injection device is described including a detection unit that includes an electrode that detects electrical characteristics of a biological tissue, a follow-up mechanism that follows motions of the biological tissue, and a puncture unit capable of puncturing the biological tissue. The injection device is configured to administer a predetermined substance to the biological tissue through a hollow portion defined in the puncture unit. A position of the puncture unit is specified based on a position of the electrode. The follow-up mechanism includes a spiral portion spirally extending around the puncture unit, and being stretchable and compressible along an extending direction of the puncture unit. Electrodes are disposed on an annular distal-end projected plane of the spiral portion, as seen from a distal end side of the puncture unit, along a circumferential direction of the puncture unit.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: September 27, 2022
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventors: Satoshi Sawada, Naoya Shimada
  • Patent number: 11452800
    Abstract: A mechanical fluid pressure modification valve, or “MFLP-valve”, is set forth. The MFLP-valve can be actuated upon movement of a movable pressure system member of a medical pressure system reaching a selected position. Additionally, the MFLP-valve can be actuated based on a pressure condition of the system. When the MFLP-valve unseals, a pressure differential between a pressure chamber and a volume outside of the chamber can be relieved. Disengagement of the movable pressure system member from the MFLP-valve can enable the MFLP-valve to re-seal. The MFLP-valve may include a flag that indicates the position of the movable pressure system member. The MFLP-valve may be provided in a diaphragm-type pressure source.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: September 27, 2022
    Assignee: MEDELA HOLDING AG
    Inventors: Jahi Gist, David Y. Cho, Mario Rigert
  • Patent number: 11452813
    Abstract: A therapy delivery device stores a plurality of time-dependent therapy settings. The therapy delivery device is configured to administer time-dependent therapies according to the time-dependent therapy settings based on a universal conception of time that is independent of a local time zone. A mobile device includes a display adapted to depict information about therapy or therapy-related data as compared to a local time that is stored on the mobile device based on a local time zone setting found in the mobile device. The therapy delivery device and a mobile application executing on the mobile device are configured to keep separate clocks, with each clock being based on a universal concept of time that is independent of a local time zone.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: September 27, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Alexander Howard Worden, Kilty McGowan, Pawel Drozdz, Ross Naylor, Kevin S. Lee
  • Patent number: 11446478
    Abstract: The device of the present invention comprises an intervening release liner as a common special feature, and the intervening release liner covers a part of an adhesive surface of a patch. The intervening release liner gets away from the patch, and is fixed to a patch application support (or porator tab). Due to such constitution, under a situation in use where the first part of the adhesive area of the patch adheres to a skin surface, the patch application support is slidable along the skin surface while peeling the intervening release liner from said part of the adhesive area of the patch to adhere to the skin surface.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: September 20, 2022
    Assignee: Passport Technologies, Inc.
    Inventors: Serge Roux, Christopher Kadamus, Bernadette C. Messier, Uros Kascak, Nathan Barr
  • Patent number: 11446177
    Abstract: Embodiments of the invention provide apparatus, systems and method for introducing fluids into a body cavity for treatment. One embodiment provides an apparatus for treating a patient including an access device for insertion into the peritoneal cavity of the patient including an infusion member in a lumen of the access device. An oxygenated solution may be infused and removed into and out of the cavity via the infusion member.
    Type: Grant
    Filed: March 23, 2022
    Date of Patent: September 20, 2022
    Assignee: TheraNova, LLC
    Inventors: Daniel R. Burnett, Shane Mangrum
  • Patent number: 11445974
    Abstract: A system for adjusting blood glucose level including an insulin delivery device configured to release insulin into the body of a person, and an EEG monitor having an EEG sensing part including EEG electrodes. The EEG monitor can be arranged in the ear region of the person with the EEG sensing part arranged subcutaneously at the scalp or arranged in the ear canal. The EEG monitor includes an EEG signal processor arranged at the ear and adapted for identifying onset of hypoglycemia. The system further includes a wireless link between the EEG monitor and the insulin delivery device. The EEG monitor is configured to submit a warning signal to the insulin delivery device if an upcoming onset of hypoglycemia is identified. The warning message will cause the insulin delivery device to restrict insulin delivery for a predetermined time, and a warning is provided to the person or to a caregiver.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: September 20, 2022
    Assignee: T&W Engineering A/S
    Inventors: Rasmus Stig Jensen, Richard Topholm, Erik Skov Christensen, Rasmus Elsborg Madsen
  • Patent number: 11439734
    Abstract: The present invention relates to an expression kit (2) for a breast pump (1) for extracting breast milk (101) from a human teat (102). The expression kit (2) comprises: a breast pump body (10) comprising a first pressure chamber (11) and a second pressure chamber (21); wherein the first pressure chamber (11) is configured for connection to a pressure unit (30) for generating a in the pressure chamber (11); wherein the second pressure chamber (21) comprises a breast-receiving funnel (22), a milk outlet (23) and a milk path (24) from the breast-receiving funnel (22) to the milk outlet (23); and wherein the first and the second pressure (11, 21) chamber are separated by a breathable membrane (50), which is gas-permeable and liquid-impermeable, for separating the first pressure chamber (11) from liquid in the milk path (24), wherein the breathable membrane (50) is a hydrophobic membrane. Further, the present invention relates to a breast pump (1).
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: September 13, 2022
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Arnold Aalders, Roy Emile Beunen, Lauret Francisca Stulemeijer
  • Patent number: 11439772
    Abstract: A hollow needle, for use in medical and other areas where thin hollow needles are used to inject or aspirate fluids and gases, is provided and comprises of a thin, rigid tube body that is open on both ends and throughout the length with one sharp end. The needle body is designed and can be manufactured with a curved shape and or other geometric features, can be drawn to a desired curvature with heat, or can be curved afterwards, to specific specifications depending on the application. The needle so configured advantageously allows the user to circumvent an obstacle and or obstacles that otherwise inhibit direct linear access to a point-of-interest by providing a device that can take the sharp point of a needle on an indirect path towards the desired therapy delivery point.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: September 13, 2022
    Assignee: Jasperate, Inc.
    Inventors: David Weksel, Stephen Soloway, Alyxandra Morgan Soloway, Estella Yang Huang, Jacob Oliver Soloway, Justine K. Weksel, Charles S. Brunner
  • Patent number: 11439764
    Abstract: The present invention relates to a monitoring device (10) arranged to be operably connected to a medicament delivery device (12), said medicament delivery device (12) comprising a manually operated movable dose activation element (20), said monitoring device (10) comprising an electronic circuit (42), said electronic circuit (42) comprising an optical sensor (68), wherein said optical sensor (68) is positioned in relation to said dose activation element (20) so as to detect a manual operation of said dose activation element (20) from an initial position; said electronics circuit further comprising a vibration sensor (70), wherein said vibration sensor (70) is positioned in relation to said medicament delivery device so as to detect specific vibration spectra produced by the medicament delivery device when said dose activating element (20) is operated, wherein said electronic circuit (42) comprises computing elements capable of correlating the information from the optical sensor (68) with the information from
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: September 13, 2022
    Assignee: SHL MEDICAL AG
    Inventor: William Cirillo
  • Patent number: 11439769
    Abstract: A needle assembly for mounting on an injection device which comprises a body configured to be attached to an injection device in use; a double ended needle and a needle shield coupled to the body. The needle shield is arranged for axial movement with respect to the body. The needle assembly has an injection configuration, in which the shield is positioned such that the forward tip of the needle projects beyond a forward end of the shield. The needle assembly also has a shroud configuration, in which the shield is positioned such that the forward end of the shield extends beyond the forward tip of the needle. The needle assembly further comprises a needle support fixed relative to the body when the needle assembly is in the injection configuration. Movement of the shield from the injection configuration to the shroud configuration axially displaces the needle support relative to the body.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: September 13, 2022
    Assignee: Owen Mumford Limited
    Inventor: Jack Calvert
  • Patent number: 11439572
    Abstract: The present disclosure provides a device that includes a tube having a first end and a second end. The device also includes a stopper coupled to a surface of the tube adjacent to the second end of the tube. The stopper is configured to extend radially from the surface of the tube. The device also includes a first rib coupled to the surface of the tube. The device also includes a second rib coupled to the surface of the tube. The first rib and the second rib are positioned opposite one another on the surface of the tube between the first end of the tube and the stopper.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: September 13, 2022
    Assignee: Sanford Health
    Inventors: Steven Briggs, Patrick W. Kelly
  • Patent number: 11439796
    Abstract: Inflation devices configured to communicate with remote displays are disclosed herein. Systems including such inflation devices with portable display devices are also disclosed herein. Methods of pairing a medical device to a portable display and remotely displaying pressure data from a medical device are also disclosed herein. Devices, systems, and methods of connecting medical devices to remote displays using proximity pairing and visual aids, and transferring information to or from linked computers are also disclosed.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: September 13, 2022
    Assignee: Merit Medical Systems, Inc.
    Inventors: Jon Davis, Tamara Smith Duncan, David Mandel, Christopher Rice, Zachary Glickstein, Christopher Hile, Jeremy Mushailov
  • Patent number: 11439770
    Abstract: The present disclosure relates to an injection device. The injection device comprises a body for holding a syringe having a needle extending from one end thereof and a cap that is removably attached to the body. The cap has a needle shield to cover said needle. The injection device further comprises a biasing member and a lock. The biasing member is configured to urge at least a part of the cap away from the body. The lock is moveable between a locked state, wherein the lock holds the cap and body together, and an unlocked state, wherein the cap and body are able to move apart.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: September 13, 2022
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Stefan Wendland, Michael Harms, Uwe Dasbach, Jan Torben Eickriede
  • Patent number: 11439750
    Abstract: A medication delivery patch that is applied to the skin and activated to deliver a medication or other fluid into or through the skin. The patch may be completely mechanically driven, with no electronic components, for low cost, safety, and reliability. Pressing an activation button may set in motion a sequence of mechanical events that result in a needle exiting the patch into the skin of the user, and flow of fluid from an internal pouch in the patch into the user. When delivery is complete, another sequence of mechanical events may occur to retract the needle from the skin and stop the flow of fluid, and to show a visible indicator that delivery is complete. The patch may contain a fluid channel, such as a microfluidic channel, that controls the rate and time of delivery; this channel can be configured or selected for different medications or use cases.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: September 13, 2022
    Inventor: Gina G. Stetsko